Skip to main content
lexblog.com/lib/6SCXNRD6viewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FCA Issues to Watch: Pharmaceutical and Device Developments",
    "url": "https://www.lexblog.com/2017/05/15/fca-issues-to-watch-pharmaceutical-and-device-developments/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-6SCXNRD6",
        "url": "https://www.lexblog.com/lib/6SCXNRD6/"
    },
    "datePublished": "2017-05-15T15:40:17-04:00",
    "dateModified": "2022-08-17T08:26:48-04:00",
    "author": {
        "@type": "Person",
        "name": "Bass, Berry & Sims"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Bass, Berry & Sims PLC"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Inside the False Claims Act",
    "about": "Criminal ยท Health Care and Life Sciences",
    "sourceUrl": "http://www.insidethefca.com/?p=2007",
    "sourceStability": "may-move"
}